Trial Profile
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Jun 2014
Price :
$35
*
At a glance
- Drugs Efinaconazole (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Dow Pharmaceutical Sciences
- 05 Jun 2014 New trial record